{{Rsnum
|rsid=2413775
|Gene=SLC28A2
|Chromosome=15
|position=45252090
|Orientation=minus
|GMAF=0.4876
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=LOC101928414,SLC28A2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 1.5 | 43.1 | 55.4
| HCB | 61.4 | 36.4 | 2.3
| JPT | 66.7 | 33.3 | 0.0
| YRI | 22.2 | 50.8 | 27.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 61.4 | 36.4 | 2.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs2413775
|Name_s=SLC28A2: ?146T>a
|Gene_s=SLC28A2
|Feature=Intron
|Evidence=PubMed ID:19940846
|Annotation=&#8722;146a allele showed increased luciferase activity in reporter assays in cells and in vivo assay.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA165111584
}}

{{PMID Auto
|PMID=19098160
|Title=Identification and characterization of proximal promoter polymorphisms in the human concentrative nucleoside transporter 2 (SLC28A2).
|OA=1
}}

{{PMID Auto
|PMID=19742321
|Title=Genetic variation in the proximal promoter of ABC and SLC superfamilies: liver and kidney specific expression and promoter activity predict variation.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2413775
|overall_frequency_n=71
|overall_frequency_d=128
|overall_frequency=0.554688
|n_genomes=38
|n_genomes_annotated=0
|n_haplomes=54
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}